|
Market Closed -
Nasdaq
00:00:00 02/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 10.57 USD | +0.76% |
|
-2.85% | -12.93% |
| 08-19 | Ocular Therapeutix, Inc. - Special Call | |
| 08-04 | Ocular Therapeutix's NDA Plans for Axpaxli in Wet AMD Remain on Track, RBC Says | MT |
| Market Cap | 2.32B 2B 1.88B 1.72B 3.23B 220B 3.24B 22.27B 8.67B 112B 8.72B 8.53B 372B | P/E 2026 * |
-7.09x | P/E 2027 * | -7.59x |
|---|---|---|---|---|---|
| Enterprise Value | 1.94B 1.68B 1.58B 1.44B 2.7B 184B 2.72B 18.64B 7.26B 93.82B 7.3B 7.14B 311B | EV / Sales 2026 * |
36.7x | EV / Sales 2027 * | 22x |
| Free-Float |
99.07% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Ocular Therapeutix, Inc.
| 1 day | +0.76% | ||
| 1 week | -2.85% | ||
| Current month | +0.76% | ||
| 1 month | +29.38% | ||
| 3 months | +18.37% | ||
| 6 months | +18.23% | ||
| Current year | -12.93% |
| 1 week | 10.13 |  | 10.97 |
| 1 month | 8.18 | | 11.74 |
| Current year | 6.23 | | 13.03 |
| 1 year | 6.23 | | 16.44 |
| 3 years | 2 | | 16.44 |
| 5 years | 2 | | 16.44 |
| 10 years | 2 | | 24.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pravin Dugel
CEO | Chief Executive Officer | 62 | 15/04/2024 |
Jason Robins
DFI | Director of Finance/CFO | 50 | 20/01/2026 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 49 | 20/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Warden
CHM | Chairman | 57 | 01/07/2019 |
| Director/Board Member | 78 | 05/11/2012 | |
Leslie Williams
BRD | Director/Board Member | 66 | 20/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/08/26 | Don | Chief Executive Officer | -100,184 | 0.0473% | ||
| 24/08/26 | Sell | Executive/Senior Manager | -3,035 | 0.0014% | ||
| 24/08/26 | Sell | Chief Technology Officer | -3,296 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.76% | -2.85% | -13.43% | +173.13% | 2.32B | |
| +0.28% | -5.97% | +58.34% | +108.22% | 1,034B | |
| +2.01% | -0.71% | +53.07% | +68.99% | 654B | |
| +1.39% | -2.18% | +23.57% | +75.43% | 459B | |
| +0.71% | -5.08% | +33.44% | +35.69% | 343B | |
| -0.63% | +2.34% | +28.62% | +46.20% | 307B | |
| -0.38% | -2.70% | 0.00% | +11.36% | 251B | |
| +1.92% | -0.93% | +52.28% | +70.67% | 237B | |
| +0.35% | -3.61% | -17.99% | -55.15% | 202B | |
| +2.45% | +0.77% | +32.71% | +95.59% | 186B | |
| Average | +1.02% | -2.88% | +25.06% | +63.01% | 367.39B | |
| Weighted average by Cap. | +1.23% | -3.31% | +38.34% | +66.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 52.93M 45.66M 42.95M 39.12M 73.57M 5.02B 73.97M 508M 198M 2.56B 199M 194M 8.47B | 102M 88.4M 83.15M 75.75M 142M 9.73B 143M 983M 383M 4.95B 385M 376M 16.4B |
| Net income | -334M -288M -271M -247M -465M -31.73B -467M -3.21B -1.25B -16.14B -1.26B -1.23B -53.51B | -324M -280M -263M -240M -451M -30.79B -453M -3.11B -1.21B -15.66B -1.22B -1.19B -51.93B |
| Net Debt | -378M -326M -307M -279M -525M -35.87B -528M -3.63B -1.41B -18.25B -1.42B -1.39B -60.51B | -66M -56.93M -53.55M -48.79M -91.74M -6.26B -92.24M -633M -246M -3.19B -248M -242M -10.57B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | $10.57 | +0.76% | 1,578,326 |
| 31/08/26 | $10.49 | +1.25% | 1,520,523 |
| 28/08/26 | $10.36 | -4.25% | 1,563,599 |
| 27/08/26 | $10.82 | +0.46% | 1,427,221 |
| 26/08/26 | $10.77 | -1.01% | 1,368,113 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCUL Stock
Select your edition
All financial news and data tailored to specific country editions
